Actively Recruiting
LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
Led by Centre Leon Berard · Updated on 2024-08-21
900
Participants Needed
8
Research Sites
595 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this project is to characterize the genetic profile of patients with advanced stage IIIB/IV non-small cell lung cancer (NSCLC) using liquid biopsies
CONDITIONS
Official Title
LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with histologically confirmed advanced non-small-cell lung carcinoma (stage IIIB/IV) regardless of mutation status
- Inclusion at the time of diagnosis
- Tumor biopsy performed at Centre Léon Bérard or elsewhere with an available histopathological report
- Age 18 years or older
- Covered by health insurance
- Signed informed consent
- For cohort 2: presence of molecular anomalies such as EGFR, BRAF, HER2 mutations, ALK or ROS1 translocations, MET amplification, or RET rearrangement
- For cohort 3: inclusion at the start of immunotherapy treatment (first or second line)
You will not qualify if you...
- Patients who have received treatment before their liquid biopsy
- Patients who have started immunotherapy before their liquid biopsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Centre Hospitalier Annecy Genevois
Annecy, France
Active, Not Recruiting
2
CH Fleyriat
Bourg-en-Bresse, France
Active, Not Recruiting
3
Hôpital Louis Pradel
Bron, France, 69677
Active, Not Recruiting
4
CHU Grenoble Alpes
Grenoble, France
Active, Not Recruiting
5
Centre Léon Bérard
Lyon, France, 69008
Actively Recruiting
6
CHRU de Saint-Etienne
Saint-Priest-en-Jarez, France, 42270
Active, Not Recruiting
7
Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, France, 42270
Active, Not Recruiting
8
Hôpital Nord Ouest
Villefranche-sur-Saône, France, 69655
Active, Not Recruiting
Research Team
P
Pierre Saintigny, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here